News
-
Viatris and Theravance Biopharma say that a Phase 3 trial of Yupelri revefenacin inhalation solution for the treatment of COPD conducted in China met its primary endpoint and that Viatris expects to file a marketing application… Read more . . .
-
Milestone Pharmaceuticals has published data from the Phase 2 ReVeRA trial of etripamil nasal spray in patients experiencing atrial fibrillation with rapid ventricular rate (AFib-RVR) that the company says “support further development of self-administered etripamil… Read more . . .
-
Altamira Therapeutics (formerly Auris Medical) said that the European Patent Office (EPO) has issued a notice that it will grant a patent (No. 3698791) covering the company’s AM-125 intranasal formulation of betahistine until February 2038.… Read more . . .
-
OINDP testing specialists Copley Scientific have launched new versions of their Vertus automated shake and fire system for testing of MDIs and nasal sprays. According to Copley, the Vertus III+ is “comprehensively updated to meet testing requirements… Read more . . .
-
TFF Pharmaceuticals has published a paper on bioRxiv titled “Feasibility of Intranasal Delivery of Thin-film Freeze-dried Monoclonal Antibodies” describing characterization and deposition studies of TFF’s dry powder AUG-3387 mAbs delivered by Aptar Pharma‘s Unidose (UDS)… Read more . . .
-
The United States Federal Trade Commission (FTC) announced that it has challenged the Orange Book listings of more than 100 patents related to combination products, with most of those patents related to inhaler device components… Read more . . .
-
After recently raising $175 million for continued development of AP01 inhaled pirfenidone and AP02 inhaled nintedanib, Avalyn Pharma has announced four new executive hires. The new appointments include former Boehringer Ingelheim interstitial lung disease (ILD)… Read more . . .
-
According to Acorda Therapeutics, Biopas Laboratories has submitted marketing applications for Inbrija levodopa inhalation powder for the treatment of OFF episodes in Parkinson’s disease in Argentina, Colombia, Costa Rica, Ecuador, Panama, and Peru. In May 2022,… Read more . . .
-
The International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC‑RS) is highlighting the recent publication of a new paper titled “Laboratory Performance Testing of Aqueous Nasal Inhalation Products for Droplet/Particle Size Distribution: an Assessment from… Read more . . .
-
Inhalon Biopharma announced that it has licensed human metapneumovirus (hMPV) antibodies from the University of Georgia and intends to develop inhaled hMPV antibodies for the treatment of hMPV respiratory infections. According to the company’s website,… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden